Aleeza Furman

2 weeks ago | law.com | Aleeza Furman

It looks like a Depo-Provera mass tort will not be in Philadelphia’s immediate future. Last week, Pfizer Inc. rescinded its request that the Philadelphia Court of Common Pleas create a coordinated program for litigation over the injectable contraceptive drug Depo-Provera after an anticipated influx of new filings did not materialize.

2 weeks ago | law.com | Aleeza Furman

The Pennsylvania Commonwealth Court ruled Monday that the Philadelphia School District must face negligence claims arising from a student-on-student sexual assault that allegedly occurred in a district high school. The ruling is a significant win for plaintiffs as courts grapple with the scope of a Pennsylvania statute allowing sex abuse lawsuits against state agencies. The case, captioned L.F.V. v.

3 weeks ago | law.com | Aleeza Furman

Who Got The Work J. Brugh Lower of Gibbons has entered an appearance for industrial equipment supplier Devco Corporation in a pending trademark infringement lawsuit. The suit, accusing the defendant of selling knock-off Graco products, was filed Dec. 18 in New Jersey District Court by Rivkin Radler on behalf of Graco Inc. and Graco Minnesota. The case, assigned to U.S. District Judge Zahid N. Quraishi, is 3:24-cv-11294, Graco Inc. et al v. Devco Corporation.

3 weeks ago | law.com | Aleeza Furman

The Pennsylvania Superior Court on Monday threw out a defense verdict in a medical malpractice case against a Paoli hospital. The three-judge panel held in its precedential opinion that the trial court had improperly barred the plaintiffs from cross-examining the defendants’ expert about an article he authored that conflicted with his testimony. As a result, the Superior Court ruled, the jury missed out on important information that might have colored its evaluation of the expert’s credibility.

3 weeks ago | law.com | Aleeza Furman

Mass tort coordination could be on the horizon for a collection of Philadelphia lawsuits tying the injectable contraceptive drug Depo-Provera to brain tumors. Pfizer Inc., which manufactures the branded version of Depo-Provera, last week asked the Philadelphia Court of Common Pleas to coordinate litigation over the drug and its authorized generic equivalents into a mass tort.